We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKBK icon
2701
Parke Bancorp
PKBK
$405M
$8K ﹤0.01%
+373
New +$7.52K
PRAA icon
2702
PRA Group
PRAA
$755M
$8K ﹤0.01%
+279
New +$7.89K
PWZ icon
2703
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.16B
$8K ﹤0.01%
301
QCRH icon
2704
QCR Holdings
QCRH
$1.7B
$8K ﹤0.01%
233
+136
+140% +$4.63K
QTEC icon
2705
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.83B
$8K ﹤0.01%
92
-18,168
-99% -$1.53M
LNAI
2706
Lunai Bioworks
LNAI
$10.9M
$8K ﹤0.01%
+20
New +$9.75K
SDY icon
2707
State Street SPDR S&P Dividend ETF
SDY
$23.9B
$8K ﹤0.01%
80
-419
-84% -$41.9K
SENEB
2708
Seneca Foods Class B
SENEB
$1.13B
$8K ﹤0.01%
298
-3
-1% -$78
SLGL icon
2709
Sol-Gel Technologies
SLGL
$288M
$8K ﹤0.01%
87
+6
+7% +$479
SMFG icon
2710
Sumitomo Mitsui Financial
SMFG
$164B
$8K ﹤0.01%
1,127
-14,136
-93% -$100K
SONY icon
2711
Sony
SONY
$138B
$8K ﹤0.01%
770
-18,295
-96% -$180K
SPRO icon
2712
Spero Therapeutics
SPRO
$73M
$8K ﹤0.01%
+718
New +$8.64K
SSBI icon
2713
Summit State Bank
SSBI
$90.8M
$8K ﹤0.01%
803
-22
-3% -$228
TRVG
2714
trivago
TRVG
$397M
$8K ﹤0.01%
361
+79
+28% +$1.61K
VRIG icon
2715
Invesco Variable Rate Investment Grade ETF
VRIG
$1.83B
$8K ﹤0.01%
+320
New +$7.97K
VTIP icon
2716
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$8K ﹤0.01%
160
+119
+290% +$5.83K
YARW
2717
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
-1
Closed -$24.7K
XNCR icon
2718
Xencor
XNCR
$1.55B
$8K ﹤0.01%
+184
New +$6.04K
FBMS
2719
DELISTED
The First Bancshares, Inc.
FBMS
$8K ﹤0.01%
+258
New +$7.89K
AGR
2720
DELISTED
Avangrid, Inc.
AGR
$8K ﹤0.01%
+167
New +$8.48K
VBIV
2721
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$8K ﹤0.01%
+229
New +$12.4K
ONCT
2722
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$8K ﹤0.01%
58
+39
+205% +$6.02K
SGEN
2723
DELISTED
Seagen Inc. Common Stock
SGEN
$8K ﹤0.01%
122
-217
-64% -$15.2K
ACER
2724
DELISTED
Acer Therapeutics Inc
ACER
$8K ﹤0.01%
+2,202
New +$42K
SNLN
2725
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
$8K ﹤0.01%
469
-107
-19% -$1.9K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.